These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9120257)

  • 1. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
    Blanchard DA; Affredou MT; Vazquez A
    J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
    Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
    J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking.
    Kobayashi K; Phuchareon J; Inada K; Tomita Y; Koizumi T; Hatano M; Miyatake S; Tokuhisa T
    J Immunol; 1997 Mar; 158(5):2050-6. PubMed ID: 9036948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.
    Mori S; Murakami-Mori K; Bonavida B
    Biochem Biophys Res Commun; 1999 Apr; 257(2):609-14. PubMed ID: 10198259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation.
    Liu J; Flanagan WM; Drazba JA; Estes ML; Barnett GH; Haqqi T; Kondo S; Barna BP
    J Immunol; 1997 Jul; 159(2):812-9. PubMed ID: 9218599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation.
    Wagner EF; Hleb M; Hanna N; Sharma S
    J Immunol; 1998 Aug; 161(3):1123-31. PubMed ID: 9686570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
    Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL; McLean TI; Bachenheimer SL
    Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
    Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
    Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR; Koretzky GA
    J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
    Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
    Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
    Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
    Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL; Seth P; Jetten AM
    Oncogene; 1997 May; 14(17):2111-22. PubMed ID: 9160891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
    Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.